TS-074578 — Opportunity Overview This technology is a web‑based, multi‑user platform designed to rigorously study how people interact with AI systems in real time. Unlike traditional survey tools or product A/B testing environments, the platform supports live human–AI collaboration while capturing …

TS-074316 — Pre‑Launch Start‑Up Opportunity: Seeking Business Leads ElectroTag is a multiplex diagnostics platform that enables simultaneous measurement of multiple disease‑associated proteins from a small patient sample. The system replaces conventional color‑based labels with mass‑encoded peptide tags that are read by mass spectrometry, delivering higher analytical specificity and a clear path to expanding from small to large biomarker panels while maintaining streamlined workflows.

TS-074315 — Pre‑Launch Start‑Up Opportunity ElectroFuel‑MES offers an electrified bioprocess that turns heterogeneous food and agricultural waste streams into higher‑value fuels and chemicals, providing an energy‑efficient alternative to anaerobic digestion and thermochemical treatment.

TS-074271 — Predictable, chemistry level control of biodegradable polymer behavior to simplify development, improve reproducibility, and enable differentiated biomedical products.

TS-074223 — Researchers at The Ohio State University have developed a self‑regulating manufacturing platform for porous polymer meshes that integrates mesh formation and drug loading in a single step, enabling controlled local delivery from implantable materials.

TS-074220 — This technology advances a new class of plant‑derived small‑molecule analogues with demonstrated activity against mosquito vectors, enabling early‑stage exploration of alternative insecticide mechanisms for vector control.

TS-074219 — This early‑stage electrochemical platform enables integrated CO₂ capture and permanent mineralization while supporting lower‑energy hydrogen production, offering a research‑driven pathway toward energy system decarbonization.

TS-074218 — This HIV-focused technology introduces a novel strategy for engaging conserved viral biology that is not directly addressed by existing antiretroviral classes. By expanding the range of actionable HIV mechanisms, the approach creates new opportunities for therapeutic discovery, combination strategies, and next‑generation intervention concepts. The technology is designed to complement current HIV treatment paradigms while supporting diversification of long‑term antiviral pipelines.

TS-074217 — An OSU innovation may enable farmers to actively manage water at the field scale to improve crop performance, input efficiency, and operational profitability.

TS-074216 — Reducing debris‑related drainage failures while lowering maintenance risk and lifecycle costs for transportation infrastructure owners.